期刊文献+

客观评价和正确开展结直肠癌的新辅助治疗 被引量:9

Neoadjuvant therapy of colorectal cancer
原文传递
导出
摘要 结直肠癌的新辅助治疗应遵循以下原则:(1)对于II期,III期的直肠癌病人应进行术前新辅助治疗。具体方案可采用放疗或放化疗联合。但不推荐单纯化疗。(2)对于不伴有远处转移的结肠癌病人不推荐术前新辅助治疗。仅对于可切除结肠癌肝转移病人可行新辅助化疗,以达缩小病灶,杀灭潜在转移灶之目的。 The principles of neoadjuvant therapy in colorectal cancer are as follows: 1. Rectal cancer patients of stage Ⅱ and Ⅲ should under neoadjuvant therapy. Specific strategies could be radiotherapy or with concurrent chemotherapy. Chemotherapy alone is not recommended. 2. Neoadjuvant chemotherapy is not recommended in colon cancer patients without metastasis. It is suggested only for patients with resectable liver metastasis to achieve the aim of tumor recession and diminishing micrometastasis.
作者 顾晋 杜敬曾
出处 《中国实用外科杂志》 CSCD 北大核心 2011年第1期47-49,共3页 Chinese Journal of Practical Surgery
关键词 中低位直肠癌 新辅助治疗 术前放疗 middle-lower rectal cancer neoadjuvant therapy pre-operative radio therapy
  • 相关文献

参考文献12

  • 1中下段直肠癌外科治疗规范(草案)[J].中华胃肠外科杂志,2005,8(1):88-90. 被引量:64
  • 2Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in reseetable rectal cancer [J]. N Engl J Med, 1997, 336(14): 980-987. 被引量:1
  • 3Poon RT, Chu KW, Ho JW, et al. Prospective evaluation of selective defunetioning stoma for low anterior resection with total mesorectal excision [J]. WoAd J Surg,1999,23(5): 463-467. 被引量:1
  • 4Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial[J]. Lancet, 2009,373(9666): 811-820. 被引量:1
  • 5Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J]. N Engl J Med, 2004,351(17): 1731-1740. 被引量:1
  • 6Van Cutsem E, Nordlinger B, Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases [ J ]. Eur J Cancer,2006,42( 14): 2212-2221. 被引量:1
  • 7Yoo PS, Lopez-Soler RI, Longo WE, et al. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab[J], Clin Colorectal Cancer, 2006,6(3): 202-207. 被引量:1
  • 8Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases [J]. Ann Surg,2002,235(6): 759-766. 被引量:1
  • 9Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrenee after hepatic resection for colorectal metastases [J]. Ann Surg,2005,241(5): 715-722, discussion 22-24. 被引量:1
  • 10Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement[J]. Ann Surg Oncol, 2006,13(10): 1261-1268. 被引量:1

共引文献63

同被引文献92

引证文献9

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部